China
· Delayed Price · Currency is CNY Chengdu Kanghong Pharmaceutical Group Statistics
Total Valuation
Chengdu Kanghong Pharmaceutical Group has a market cap or net worth of CNY 17.90 billion. The enterprise value is 12.36 billion.
| Market Cap | 17.90B |
| Enterprise Value | 12.36B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | May 28, 2024 |
Share Statistics
Chengdu Kanghong Pharmaceutical Group has 919.78 million shares outstanding. The number of shares has increased by 0.56% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 919.78M |
| Shares Change (YoY) | +0.56% |
| Shares Change (QoQ) | -2.68% |
| Owned by Insiders (%) | 38.79% |
| Owned by Institutions (%) | 6.02% |
| Float | 266.59M |
Valuation Ratios
The trailing PE ratio is 14.97 and the forward PE ratio is 14.31.
| PE Ratio | 14.97 |
| Forward PE | 14.31 |
| PS Ratio | 4.09 |
| PB Ratio | 2.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.62 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.12, with an EV/FCF ratio of 9.40.
| EV / Earnings | 10.36 |
| EV / Sales | 2.83 |
| EV / EBITDA | 8.12 |
| EV / EBIT | 9.88 |
| EV / FCF | 9.40 |
Financial Position
The company has a current ratio of 8.43, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.43 |
| Quick Ratio | 7.80 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.72% and return on invested capital (ROIC) is 9.75%.
| Return on Equity (ROE) | 14.72% |
| Return on Assets (ROA) | 8.88% |
| Return on Capital (ROIC) | 9.75% |
| Revenue Per Employee | 1.02M |
| Profits Per Employee | 278,180 |
| Employee Count | 4,289 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.02% in the last 52 weeks. The beta is 0.08, so Chengdu Kanghong Pharmaceutical Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +9.02% |
| 50-Day Moving Average | 19.12 |
| 200-Day Moving Average | 19.52 |
| Relative Strength Index (RSI) | 47.90 |
| Average Volume (20 Days) | 11,291,294 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Chengdu Kanghong Pharmaceutical Group had revenue of CNY 4.37 billion and earned 1.19 billion in profits. Earnings per share was 1.30.
| Revenue | 4.37B |
| Gross Profit | 3.91B |
| Operating Income | 1.25B |
| Pretax Income | 1.39B |
| Net Income | 1.19B |
| EBITDA | 1.52B |
| EBIT | 1.25B |
| Earnings Per Share (EPS) | 1.30 |
Balance Sheet
The company has 5.55 billion in cash and 6.28 million in debt, giving a net cash position of 5.54 billion or 6.02 per share.
| Cash & Cash Equivalents | 5.55B |
| Total Debt | 6.28M |
| Net Cash | 5.54B |
| Net Cash Per Share | 6.02 |
| Equity (Book Value) | 8.43B |
| Book Value Per Share | 9.17 |
| Working Capital | 5.47B |
Cash Flow
In the last 12 months, operating cash flow was 1.47 billion and capital expenditures -152.96 million, giving a free cash flow of 1.31 billion.
| Operating Cash Flow | 1.47B |
| Capital Expenditures | -152.96M |
| Free Cash Flow | 1.31B |
| FCF Per Share | 1.43 |
Margins
Gross margin is 89.53%, with operating and profit margins of 28.62% and 27.30%.
| Gross Margin | 89.53% |
| Operating Margin | 28.62% |
| Pretax Margin | 31.81% |
| Profit Margin | 27.30% |
| EBITDA Margin | 34.79% |
| EBIT Margin | 28.62% |
| FCF Margin | 30.07% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 1.94%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 1.94% |
| Dividend Growth (YoY) | 153.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 29.28% |
| Buyback Yield | -0.56% |
| Shareholder Yield | 1.38% |
| Earnings Yield | 6.68% |
| FCF Yield | 7.34% |
Stock Splits
The last stock split was on June 6, 2019. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 6, 2019 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
Chengdu Kanghong Pharmaceutical Group has an Altman Z-Score of 15.91.
| Altman Z-Score | 15.91 |
| Piotroski F-Score | n/a |